Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

RGC – Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings L
RGC
$20.31
Name : Regencell Bioscience Holdings L
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $10,043,069,440.00
EPSttm : -0.01
finviz dynamic chart for RGC
Regencell Bioscience Holdings L
$20.31
5.05%
$1.08
RGC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.42

Margin Of Safety %

Put/Call OI Ratio

1

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

20.19

Target Price

Analyst Recom

Performance Q

-17.14

Upside

-100.6%

Beta

1.76

Ticker: RGC




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11RGC27.350.910.196604
2026-05-12RGC27.030.830.587119
2026-05-13RGC27.420.880.057064
2026-05-14RGC27.1650.830.187278
2026-05-15RGC28.50.840.177334
2026-05-18RGC27.791.090.344451
2026-05-19RGC27.171.091.184478
2026-05-20RGC27.821.100.414888
2026-05-21RGC27.361.101.624891
2026-05-22RGC25.761.201.275135
2026-05-26RGC24.241.220.345216
2026-05-27RGC23.981.192.285311
2026-05-28RGC24.071.221.455397
2026-05-29RGC23.911.190.025383
2026-06-02RGC23.31.160.335465
2026-06-03RGC23.751.130.035609
2026-06-04RGC22.21.121.135656
2026-06-05RGC20.071.110.815680
2026-06-08RGC21.671.080.115901
2026-06-09RGC20.191.000.116214
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11RGC27.35- - -
2026-05-12RGC27.28- - -
2026-05-13RGC27.24- - -
2026-05-14RGC27.04- - -
2026-05-15RGC28.50- - -
2026-05-18RGC27.71- - -
2026-05-19RGC27.12- - -
2026-05-20RGC27.86- - -
2026-05-21RGC27.28- - -
2026-05-22RGC25.85- - -
2026-05-26RGC24.40- - -
2026-05-27RGC23.78- - -
2026-05-28RGC24.39- - -
2026-05-29RGC23.82- - -
2026-06-01RGC24.32- - -
2026-06-02RGC23.33- - -
2026-06-03RGC23.75- - -
2026-06-04RGC22.20- - -
2026-06-05RGC20.13- - -
2026-06-08RGC21.58- - -
2026-06-09RGC20.19- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11RGC0.00-7.461.48
2026-05-12RGC0.00-7.461.38
2026-05-13RGC0.00-7.461.38
2026-05-14RGC0.00-7.461.38
2026-05-15RGC0.00-7.461.38
2026-05-18RGC0.00-4.671.38
2026-05-19RGC0.00-4.671.38
2026-05-20RGC0.00-4.671.38
2026-05-21RGC0.00-4.671.38
2026-05-22RGC0.00-4.671.38
2026-05-26RGC0.0010.681.38
2026-05-27RGC0.0010.681.38
2026-05-28RGC0.0010.681.42
2026-05-29RGC0.0010.681.42
2026-06-02RGC0.0010.681.42
2026-06-03RGC0.0010.681.42
2026-06-04RGC0.0010.681.42
2026-06-05RGC0.0010.681.42
2026-06-08RGC0.0010.681.42
2026-06-09RGC0.0010.681.42
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

10.68

Beta

1.76

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

4

Growth Score

Sentiment Score

18

Actual DrawDown %

97.9

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

8222.67

P/Free Cash Flow

EPS

-0.01

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.67

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

RGC Healthcare
$20.31
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
13/25
Volume
9/15
Valuation
6/20
TP/AR
2/10
Options
4/10
RSI
33.6
Range 1M
4.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
30 /100
WEAK
Momentum
13/25
Growth
7/30
Estimates
0/20
Inst/Vol
6/15
Options
4/10
EPS Yr
0%
EPS NY
0%
52W%
14.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
Quality
2/30
Valuation
2/30
Growth
3/25
Stability
5/10
LT Trend
4/5
Quality
4
Regencell Bioscience Holdings L
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 10
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
RGC

Latest News

Caricamento notizie per RGC
stock quote shares RGC – Regencell Bioscience Holdings Ltd Stock Price stock today
news today RGC – Regencell Bioscience Holdings Ltd stock forecast ,stock prediction 2023 2024 2025
marketwatch RGC – Regencell Bioscience Holdings Ltd yahoo finance google finance
stock history RGC – Regencell Bioscience Holdings Ltd invest stock market
stock prices RGC premarket after hours
ticker RGC fair value insiders trading